Vascular smooth muscle cell differentiation - 2010

Journal of Biomedical Research

Volumn 24, Issue 3, 2010, Pages 169-180

  Miano, Joseph M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA 8 INTEGRIN; ALPHA ACTIN; ALPHA INTEGRIN; CALPONIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; GAMMA ACTIN; MICRORNA; MICRORNA 145; MYOCARDIN; MYOD PROTEIN; MYOSIN HEAVY CHAIN; PROTEIN D9; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID INDUCIBLE SERINE CARBOXYPEPTIDASE; RETINOID X RECEPTOR; SERINE CARBOXYPEPTIDASE; SERUM RESPONSE FACTOR; SMAD PROTEIN; SMOOTHELIN; TAMIBAROTENE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; TRANSGELIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY INJURY; BLOOD VESSEL INJURY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CYTOLOGY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEOPLASM; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 78549293286     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60026-7     Document Type: Review

References (111)

1. Majesky MW Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
2. Parmacek MS Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr Top Dev Biol 2001, 51:69-89.
3. Owens GK, Kumar MS, Wamhoff BR Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
4. Wang D-Z, Olson EN Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 2004, 14:558-566.
5. Rzucidlo EM, Martin KA, Powell RJ Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 2007, 45:25A-32A.
6. Miano JM Mammalian smooth muscle differentiation: origins, markers and transcriptional control. Results Probl Cell Differ 2002, 38:39-59.
7. Ruzika DL, Schwartz RJ Sequential activation of a-actin genes during avian cardiogenesis: vascular smooth muscle a-actin gene transcripts mark the onset of cardiomyocyte differentiation. J Cell Biol 1988, 107:2575-2586.
8. Li L, Miano JM, Cserjesi P, et al. SM22a, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 1996, 78:188-195.
9. Miano JM, Olson EN Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem 1996, 271:7095-7103.
10. Samaha FF, Ip HS, Morrisey EE, et al. Developmental pattern of expression and genomic organization of the calponin-h1 gene: a contractile smooth muscle cell marker. J Biol Chem 1996, 271:395-403.
11. DeRuiter MC, Rensen SSM, Coolen GPGM, et al. Smoothelin expression during chicken embryogenesis: detection of an embryonic isoform. Dev Dyn 2001, 221:460-463.
12. Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
13. Roberts GC, Gooding C, Smith CWJ Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene. EMBO J 1996, 15:6301-6310.
14. Larsson E, McLean SE, Mecham RP, et al. Do two mutually exclusive gene modules define the phenotypic diversity of mammalian smooth muscle?. Mol Genet Genomics 2008, 280:127-137.
15. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
16. Boettger T, Beetz N, Kostin S, et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009, 119:2634-2647.
17. Xin M, Small EM, Sutherland LB, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009, 23:2166-2178.
18. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
19. Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009, 105:158-166.
20. Elia L, Quintavalle M, Zhang J, et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009, 16:1590-1598.
21. Reusch P, Wagdy H, Reusch R, et al. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 1996, 79:1046-1053.
22. Albinsson S, Nordström I, Hellstrand P Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J Biol Chem 2004, 279:34849-34855.
23. Derynck R, Akhurst RJ Differentiation plasticity regulated by TGF-b family proteins in development and disease. Nat Cell Biol 2007, 9:1000-1004.
24. Sinha S, Hoofnagle MH, Kingston PA, et al. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004, 287:C1560-C1568.
25. Qiu P, Ritchie RP, Fu Z, et al. Myocardin enhances Smad3-mediated transforming growth factor-b1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22a transcription in vivo. Circ Res 2005, 97:983-991.
26. Lindahl P, Johansson BR, Levéen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
27. Hellström M, Kalén M, Lindahl P, et al. Role of PDGF-B and PDGFR-b in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
28. Passman JN, Dong XR, Wu S-P, et al. A sonic hedgehog signaling domain in the arterial adentitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci, USA 2008, 105:9349-9354.
29. Deaton RA, Su C, Valencia TG, et al. Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem 2005, 280:31172-31181.
30. Ohkawa Y, Hayashi K, Sobue K Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Comm 2003, 301:78-83.
31. Mann KM, Ray JL, Moon ES, et al. Calcineurin initiates smooth muscle differentiation in neural crest stem cells. J Cell Biol 2004, 165:483-491.
32. Lockman K, Hinson JS, Medlin MD, et al. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation be activating separate serum response factor co-factors. J Biol Chem 2004, 279:42422-42430.
33. Wamhoff BR, Lynch KR, Macdonald TL, et al. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2008, 28:1454-1461.
34. King KE, Lyle R, Weissberg PL, et al. Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor b1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 2003, 278:11661-11669.
35. Iso T, Hamamori Y, Kedes L Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003, 23:543-553.
36. Martin K, Weiss S, Metharom P, et al. Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ Res 2009, 105:214-218.
37. Boerth NJ, Dey NB, Cornwell TL, et al. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 1997, 34:245-259.
38. Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007, 27:42-48.
39. Xiao Q, Luo Z, Pepe AE, et al. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol 2009, 296:C711-C723.
40. Mack CP, Somlyo AV, Hautmann MB, et al. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 2001, 276:341-347.
41. Miano JM Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003, 35:577-593.
42. Miano JM, Long X, Fujiwara K Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 2007, 292:C70-C81.
43. Zhu H, Roy AL, Roeder RG, et al. Serum response factor affects preinitiation complex formation by TFIID in vitro. New Biologist 1991, 3:455-464.
44. Zhang SX, Gras EG, Wycuff DR, et al. Identification of direct serum response factor gene targets during DMSO induced P19 cardiac cell differentiation. J Biol Chem 2005, 280:19115-19126.
45. Philippar U, Schratt G, Dieterich C, et al. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell 2004, 16:867-880.
46. Niu Z, Li A, Zhang SX, et al. Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 2007, 19:618-627.
47. Selvaraj A, Prywes R Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Molecular Biology 2004, 5:13.
48. Sun Q, Chen G, Streb JW, et al. Defining the mammalian CArGome. Genome Res 2006, 16:197-207.
49. Johansen FE, Prywes R Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim Biophys Acta 1995, 1242:1-10.
50. Treisman R Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 1986, 46:567-574.
51. Miano JM, Tota RR, Vlasic N, et al. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 1990, 137:761-765.
52. Naftilan AJ, Gilliland GK, Eldridge CS Induction of antisense c-fos in rat aortic smooth muscle cells blocks the angiotensin II induced increases in protein synthesis. Circulation 1991, 84:II-338.
53. Lassar AB, Paterson BM, Weintraub H Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 1986, 47:649-656.
54. Davis RL, Weintraub H, Lassar AB Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
55. Tapscott SJ, Davis RL, Thayer MJ, et al. MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988, 242:405-411.
56. Wang D-Z, Chang PS, Wang Z, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001, 105:851-862.
57. Chen J, Kitchen CM, Streb JW, et al. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 2002, 34:1345-1356.
58. Wang Z, Wang D-Z, Pipes GCT, et al. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci, USA 2003, 100:7129-7134.
59. Long X, Bell RD, Gerthoffer WT, et al. Myocardin is sufficient for a SMC-like contractile phenotype. Arterioscler Thromb Vasc Biol 2008, 28:1505-1510.
60. Du K, Ip HS, Li J, et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 2003, 23:2425-2437.
61. Yoshida T, Sinha S, Dandre F, et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003, 92:856-864.
62. Zhou J, Herring BP Mechanisms responsible for the promoter-specific effects of myocardin. J Biol Chem 2005, 280:10861-10869.
63. Wang DZ, Li S, Hockemeyer D, et al. Potentiation of serum response factor activity by a family of myocardin- related transcription factors. Proc Natl Acad Sci, USA 2002, 99:14855-14860.
64. Li S, Wang D-Z, Richardson JA, et al. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci, USA 2003, 100:9366-9370.
65. Huang J, Cheng L, Li J, et al. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J Clin Invest 2008, 118:515-525.
66. Miano JM, Ramanan N, Georger MA, et al. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci, USA 2004, 101:17132-17137.
67. Fritz KE, Jarmolych J, Daoud AS Association of DNA synthesis and apparent dedifferentiation of aortic smooth muscle cells in vitro. Exp Mol Pathol 1970, 12:354-362.
68. Manderson JA, Mosse P, Safstrom JA, et al. Balloon catheter injury to rabbit carotid artery: I. Changes in smooth muscle phenotype. Arteriosclerosis 1989, 9:289-298.
69. Campbell GR, Campbell JH Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985, 42:139-162.
70. Hendrix JA, Wamhoff BR, McDonald OG, et al. 5′ CArG degeneracy in smooth muscle a-actin is required for injury-induced gene suppression in vivo. J Clin Invest 2005, 115:418-427.
71. Tharp DL, Wamhoff BR, Turk JR, et al. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006, 291:H2493-H2503.
72. Xu N, Papagiannakopoulos T, Pan G, et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells. Cell 2009, 137:647-658.
73. Liu Y, Sinha S, McDonald OG, et al. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 2005, 280:9719-9727.
74. Mano T, Luo Z, Malendowicz SL, et al. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res 1999, 84:647-654.
75. Yin F, Herring BP GATA-6 can act as a positive or negative regulator of smooth muscle-specific gene expression. J Biol Chem 2005, 280:4745-4752.
76. Wada H, Abe M, Ono K, et al. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Biochem Biophys Res Commun 2008, 374:731-736.
77. Kolodziejska KM, Ashraf HN, Nagy A, et al. c-Myb-dependent smooth muscle cell differentiation. Circ Res 2008, 102:554-561.
78. Pepe AE, Xiao Q, Zampetaki A, et al. Crucial Role of Nrf3 in Smooth Muscle Cell Differentiation From Stem Cells. Circ Res 2010, 106:870-879.
79. Chambon P The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 1994, 5:115-125.
80. Ross JS, Stagliano NE, Donovan MJ, et al. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 2001, 947:271-293.
81. Warrell RP Applications for retinoids in cancer therapy. Semin Hematol 1994, 31:1-13.
82. Miano JM, Kelly LA, Artacho CA, et al. all-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation 1998, 98:1219-1227.
83. Neuville P, Yan Z, Gidlöf A, et al. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARa-dependent signaling pathway. Arterioscler Thromb Vasc Biol 1999, 19:1430-1436.
84. Wiegman PJ, Barry WL, McPherson JA, et al. All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: a favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol 2000, 20:89-95.
85. Fujiu K, Manabe I, Ishihara A, et al. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res 2005, 97:1132-1141.
86. Drab M, Haller H, Bychkov R, et al. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J 1997, 11:905-915.
87. Mangelsdorf DJ, Umesono K, Evans RM The retinoid receptors. The retinoids: biology, chemistry, and medicine 1994, 319-349. Raven Press, New York. M.B. Sporn, A.B. Roberts, D.S. Goodman (Eds.).
88. Miano JM, Topouzis S, Majesky MW, et al. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation 1996, 93:1886-1895.
89. Chen J, Maltby KM, Miano JM A novel retinoid-response gene set in vascular smooth muscle cells. Biochem Biophys Res Comm 2001, 281:475-482.
90. Greenberg CS, Birckbichler PJ, Rice RH Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991, 5:3071-3077.
91. Ou H, Haendeler J, Aebly MR, et al. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res 2000, 87:881-887.
92. Schnapp LM, Breuss JM, Ramos DM, et al. Sequence and tissue distribution of the human integrin a8 subunit: a b1-associated a subunit expressed in smooth muscle cells. J Cell Sci 1995, 108:537-544.
93. Obata H, Hayashi K, Nishida W, et al. Smooth muscle cell phenotype-dependent transcriptional regulation of the a1 integrin gene. J Biol Chem 1997, 272:26643-26651.
94. Brandt DT, Baarlink C, Kitzing TM, et al. SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin. Nat Cell Biol 2009, 11:557-568.
95. Zargham R, Pepin J, Thibault G a8b1 integrin is up-regulated in the neointima concomitant with late luminal loss after balloon injury. Cardiovascular Pathology 2007, 16:212-220.
96. Zargham R, Thibault G a8b1 integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation. Cardiovasc Res 2005, 65:813-822.
97. Zargham R, Touyz RM, Thibault G a8 integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype. Atherosclerosis 2007, 195:303-312.
98. Zargham R, Thibault G a8 integrin expression is required for maintenance of the smooth muscle cell differentiated phenotype. Cardiovasc Res 2006, 71:170-178.
99. Wong W, Scott JD AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004, 5:959-970.
100. Gelman IH The role of SSeCKS/Gravin/AKAP12 scaffolding proteins in the spatiotemporal control of signaling pathways in oncogenesis and development. Front Biosci 2002, 7:1782-1797.
101. Streb JW, Kitchen CM, Gelman IH, et al. Multiple promoters direct expression of three AKAP12 isoforms with distinct tissue and subcellular distribution profiles. J Biol Chem 2004, 279:56014-56023.
102. Streb JW, Miano JM AKAP12a: an atypical serum response factor-dependent target gene. J Biol Chem 2005, 280:4125-4134.
103. Kwee L, Baldwin HS, Shen HM, et al. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 1995, 121:489-501.
104. Miano JM, Cserjesi P, Ligon KL, et al. Smooth muscle myosin heavy chain marks exclusively the smooth muscle lineage during mouse embryogenesis. Circ Res 1994, 75:803-812.
105. Lavie J, Dandré F, Louis H, et al. Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-kB activation. J Biol Chem 1999, 274:2308-2314.
106. Orr AW, Lee MY, Lemmon JA, et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2008, 29:225-231.
107. Chen J, Streb JW, Maltby KM, et al. Cloning of a novel retinoid-inducible serine carboxypeptidase from vascular smooth muscle cells. J Biol Chem 2001, 276:34175-34181.
108. Lee T-H, Streb JW, Georger MA, et al. Tissue expression of the novel serine carboxypeptidase Scpep1. J Histochem Cytochem 2006, 54:701-711.
109. Kollmann K, Damme M, Deuschl F, et al. Molecular characterization and gene disruption of mouse lysosomal putative serine carboxypeptidase 1. FEBS J 2009, 276:1356-1369.
110. Lee TH, Chen J, Miano JM Functional characterization of a putative serine carboxypeptidase in vascular smooth muscle cells. Circ Res 2009, 105:271-278.
111. Watson JD, Crick FHC Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 1953, 171:737-738.